Eli Lilly's Compassionate Use Program Grants Access to Experimental Obesity Drug for 79-Year-Old
In a notable case, Eli Lilly and the FDA have provided a 79-year-old patient with access to an experimental obesity drug through the compassionate use program, highlighting ethical considerations in drug access.
Editorial Staff about 10 hours ago